ES2196081T3 - Racemizacion de precursores para levobupivacaina y analogos de la mismos. - Google Patents

Racemizacion de precursores para levobupivacaina y analogos de la mismos.

Info

Publication number
ES2196081T3
ES2196081T3 ES95933510T ES95933510T ES2196081T3 ES 2196081 T3 ES2196081 T3 ES 2196081T3 ES 95933510 T ES95933510 T ES 95933510T ES 95933510 T ES95933510 T ES 95933510T ES 2196081 T3 ES2196081 T3 ES 2196081T3
Authority
ES
Spain
Prior art keywords
levobupivacaine
racemization
analogs
practice
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933510T
Other languages
English (en)
Inventor
Ulrich Conrad Dyer
Raymond Mccague
Martin Woods
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420245A external-priority patent/GB9420245D0/en
Priority claimed from GBGB9504924.3A external-priority patent/GB9504924D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of ES2196081T3 publication Critical patent/ES2196081T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE ACIDO PIPECOLICO OPTICAMENTE ENRIQUECIDO COMO UNA SAL CON UN ACIDO OPTICAMENTE ACTIVO, COMPRENDE LA TRANSFORMACION ASIMETRICA DE ACIDO PIPECOLICO, COMO UNA MEZCLA RACEMICA O UNA MEZCLA ENRIQUECIDA EN EL ENANTIOMERO OPUESTO DEL DESEADO, CON EL ACIDO OPTICAMENTE ACTIVO EN UN SOLVENTE QUE COMPRENDE UN ACIDO QUE CAUSA RACEMIZACION, EN LA AUSENCIA DE ALDEHIDO.
ES95933510T 1994-10-07 1995-10-09 Racemizacion de precursores para levobupivacaina y analogos de la mismos. Expired - Lifetime ES2196081T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420245A GB9420245D0 (en) 1994-10-07 1994-10-07 Racemisation
GBGB9504924.3A GB9504924D0 (en) 1995-03-10 1995-03-10 Racemisation

Publications (1)

Publication Number Publication Date
ES2196081T3 true ES2196081T3 (es) 2003-12-16

Family

ID=26305756

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933510T Expired - Lifetime ES2196081T3 (es) 1994-10-07 1995-10-09 Racemizacion de precursores para levobupivacaina y analogos de la mismos.

Country Status (11)

Country Link
EP (1) EP0784603B1 (es)
JP (1) JPH11510471A (es)
AT (1) ATE238256T1 (es)
AU (1) AU695740B2 (es)
CA (1) CA2201780C (es)
DE (1) DE69530499T2 (es)
DK (1) DK0784603T3 (es)
ES (1) ES2196081T3 (es)
MX (1) MX9702483A (es)
PT (1) PT784603E (es)
WO (1) WO1996011173A2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963991C3 (de) * 1969-12-20 1975-05-15 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Gewinnung eines Derivates von L-3,4-dihydroxyphenylalanin
DE3334849A1 (de) * 1983-09-27 1985-04-04 Hoechst Ag, 6230 Frankfurt Verfahren zur racemisierung optisch aktiver aminosaeuren
GB8421964D0 (en) * 1984-08-30 1984-10-03 Beecham Group Plc Chemical process
DE3435095C2 (de) * 1984-09-25 1986-07-24 Degussa Ag, 6000 Frankfurt Verfahren zur Racemisierung von N-Acetyl-D(L)-α-aminocarbonsäuren

Also Published As

Publication number Publication date
CA2201780C (en) 2007-01-09
EP0784603B1 (en) 2003-04-23
EP0784603A2 (en) 1997-07-23
AU3614095A (en) 1996-05-02
WO1996011173A3 (en) 1996-07-04
DK0784603T3 (da) 2003-08-18
WO1996011173A2 (en) 1996-04-18
MX9702483A (es) 1998-04-30
JPH11510471A (ja) 1999-09-14
PT784603E (pt) 2003-08-29
ATE238256T1 (de) 2003-05-15
AU695740B2 (en) 1998-08-20
DE69530499T2 (de) 2004-01-08
CA2201780A1 (en) 1996-04-18
DE69530499D1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
DE69525950D1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
BR9507845A (pt) Método para preparação de um composto composto enriquecido racêmica ou enantiomericamente método para preparação de composto enantiômero (+) ou (-) enantiomericamente enriquecido enantiômero (+) de um composto e compostos
DE3677399D1 (de) Verfahren zur herstellung von l-lysin.
KR890002030A (ko) 메데토 미딘의 d 및 1 에난티오머, 그 분리 방법 및 이를 포함하는 제약학적 조성물
DE69535643D1 (de) Verfahren zur fermentativen Herstellung von L-Lysin und L-glutaminsäure
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
DE69521175D1 (de) Verfahren zur Herstellung von Xanthangummi
ES2177644T3 (es) Procedimiento para la resolucion de etodolac utilizando derivados de glucamina.
ATA135687A (de) Verfahren zur herstellung von neuen 1,4-dihydropyridinen
ATE397088T1 (de) Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e
ES2196081T3 (es) Racemizacion de precursores para levobupivacaina y analogos de la mismos.
ATE200889T1 (de) Verfahren zur herstellung von enantiomerenreiner azetidin-carbonsäure
DE59205884D1 (de) Verfahren zur Herstellung der racemischen und optisch aktiven 1,2,3,4-Tetrahydroisochinolin-3-carbonsäure sowie deren Vorprodukte
ES8603385A1 (es) Procedimiento para la obtencion de determinadas parejas de enantiomeros de permetrinato de -ciano-3-fenoxi-4-fluorben- cilo
DE69713163D1 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
ATE118470T1 (de) Isolierung von l-phenylalanin aus dessen racemischen mischungen.
DE3686968D1 (de) Verfahren zur herstellung von tri-alkylbenzolsulfonaten des iminoctadine.
ATA326986A (de) Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
DE59808082D1 (de) Verfahren zur herstellung von langkettigen glycin-n,n-diessigsäure-derivaten
ATE253579T1 (de) Verfahren zur herstellung eines enantiomers von narwedin
ATA297085A (de) Verfahren zur herstellung des neuen rechtsdrehenden, optischen isomeren des diastereomeren a von ym-09730
DE68905073D1 (de) Verfahren zur herstellung von racemischen cyclopropancarbonsaeurehalogeniden.
DE3679780D1 (de) Substituierte aminosulfonyl-6-nitrobenzosaeureester oder -amide, verfahren zur herstellung und diese enthaltende heilmittel.
ATA139082A (de) Verfahren zur herstellung von neuen, optisch aktiven und racemischen 5-substituierten-4-oxo -pgi1-derivaten sowie von deren salzen